Could a common pain drug slow Parkinson's progression?
NCT ID NCT07370532
Summary
This study is testing whether adding the anti-inflammatory drug etoricoxib to standard Parkinson's treatment helps control symptoms better. Researchers will enroll 60 adults with Parkinson's who are already on conventional therapy. The goal is to see if reducing brain inflammation improves movement and other symptoms measured by standard Parkinson's rating scales.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mansoura University
Al Mansurah, 26548, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.